Security Snapshot

Lexaria Bioscience Corp. - Common Stock, par value $0.001 per share (LEXX) Institutional Ownership

CUSIP: 52886N604

13F Institutional Holders and Ownership History for Q3 2026

13F reference period

Q3 2026

Institutions Reporting

7

Shares (Excl. Options)

237.23KFull value: 237,230 · shares · 30 Sep 2026

Price

$3.08

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+237,230
Value change
+$744,013
Number of holders
7
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
2,106,291
SEC-reported price per share
$3.77
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • LEXX - Lexaria Bioscience Corp. - Common Stock, par value $0.001 per share is tracked under CUSIP 52886N604.
  • 7 institutions reported positions in Q3 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • The headline uses Q3 2026 reported holdings.
  • Quarter-over-quarter comparison is unavailable because the immediately preceding quarter is missing.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 7 institutions filings for Q3 2026.

Open SEC evidence

Security key

52886N604

13F reference period

Q3 2026

13F holders

7

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
LEXX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.2% $554,110 172,084 Armistice Capital, LLC 30 Sep 2026
As of 30 Sep 2026, 7 institutional investors reported holding
237.23KFull value: 237,230 · shares · 30 Sep 2026
shares of Lexaria Bioscience Corp. - Common Stock, par value $0.001 per share (LEXX). This represents 11% of the company’s total
2.11MFull value: 2,106,291 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 7 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
11%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 8.2% 172,084 0.02% $542,065
Invenomic Capital Management LP 1% 21,578 0% $67,971
VANGUARD CAPITAL MANAGEMENT LLC 0.94% 19,896 0% $61,180
GEODE CAPITAL MANAGEMENT, LLC 0.79% 16,689 0% $51,326
VANGUARD FIDUCIARY TRUST CO 0.3% 6,278 0% $19,305
Vanguard Global Advisers, LLC 0.03% 681 0% $2,094
Federation des caisses Desjardins du Quebec 0% 24 0% $72

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
1
Headline period
Q3 2026
Rows shown
1-1 of 1
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 237,230 $744,013 +$744,013 $3.08 7
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .